Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
This trial is to study the efficacy of nab-PC vs. GC and evaluate toxicity of nab-PC in
advanced squamous cell cancer of lung. The correlation between the efficacy of nab-PC and
some biomarkers is also to be evaluated.